Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Head and Neck Neoplasms × Digoxin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 1 Drug-drug Interaction,SHR3680 1

Interventions

Cisplatin 28 Radiotherapy 16 Paclitaxel 9 Surveys and Questionnaires 8 Fluorouracil 8 Cetuximab 8 pembrolizumab 7 durvalumab 6 Docetaxel 6 apatinib 5 Radiotherapy, Intensity-Modulated 5 Low-Level Light Therapy 5 Carboplatin 5 Standard of Care 4 Gemcitabine 4 Celecoxib 4 atezolizumab 3 Radiation 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Magnetic Resonance Imaging 3 Lidocaine 3 Immunoenzyme Techniques 3 Drug Therapy 3 Cyclophosphamide 3 Blood Specimen Collection 3 Biopsy 3 toripalimab 2 fludarabine 2 cemiplimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02906800 2017-10-19

DIGHANC

Assistance Publique - Hôpitaux de Paris

Phase 1/2 Unknown

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡